Monashee Investment Management adds BioScrip Inc (BIOS) to its portfolio

BioScrip Inc (BIOS) : Monashee Investment Management added new position in BioScrip Inc during the most recent quarter end. The investment management firm now holds 405,000 shares of BioScrip Inc which is valued at $1,057,050 , the company said in a statement filed on Aug 2, 2016 with the SEC.BioScrip Inc makes up approximately 1.62% of Monashee Investment Management’s portfolio.

Other Hedge Funds, Including , Roanoke Asset Management Corp Ny boosted its stake in BIOS in the latest quarter, The investment management firm added 112,325 additional shares and now holds a total of 277,020 shares of BioScrip Inc which is valued at $723,022. BioScrip Inc makes up approx 0.32% of Roanoke Asset Management Corp Ny’s portfolio.Advisory Services Network boosted its stake in BIOS in the latest quarter, The investment management firm added 4,300 additional shares and now holds a total of 18,700 shares of BioScrip Inc which is valued at $49,555. BioScrip Inc makes up approx 0.01% of Advisory Services Network’s portfolio. Quotient Investors sold out all of its stake in BIOS during the most recent quarter. The investment firm sold 31,800 shares of BIOS which is valued $82,044. Bnp Paribas Arbitrage Sa added BIOS to its portfolio by purchasing 2,729 company shares during the most recent quarter which is valued at $7,341.

BioScrip Inc closed down -0.01 points or -0.38% at $2.65 with 8,21,570 shares getting traded on Monday. Post opening the session at $2.53, the shares hit an intraday low of $2.5 and an intraday high of $2.6733 and the price fluctuated in this range throughout the day.Shares ended Monday session in Red.

On the company’s financial health, BioScrip Inc reported $-0.14 EPS for the quarter, missing the analyst consensus estimate by $ -0.05 based on the information available during the earnings call on Aug 8, 2016. Analyst had a consensus of $-0.09. The company had revenue of $232.50 million for the quarter, compared to analysts expectations of $227.52 million. The company’s revenue was down -11.4 % compared to the same quarter last year.

BioScrip Inc. is engaged in providing infusion and home care management solutions. The Company partners with physicians hospital systems skilled nursing facilities healthcare payers and pharmaceutical manufacturers to provide patients access to post-acute care services. Its segments include Infusion Services and Pharmacy Benefit Management (PBM) Services. Its Infusion Services segment provides services consisting of home infusion therapy respiratory therapy and the provision of durable medical equipment products and services. Its PBM Services segment consists of integrated PBM services which primarily consists of discount card programs that provide alternative for individuals who may be uninsured underinsured or may have restrictive coverage that disallows reimbursement for certain medications. It provides products services and condition-specific clinical management programs for health conditions such as gastrointestinal abnormalities infectious diseases and others.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

BioScrip Inc - Is it time to Sell?

Top Brokerage Firms are advising their investors on BioScrip Inc. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.